Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2011)

Cytomegalovirus Colitis Following Azacitidine Therapy

  • Rajal Khan,
  • Pam Rudkin,
  • Kuljit Grewal,
  • Jennifer Leonard,
  • Mowafak Hamodat,
  • Jim Hutchinson,
  • Peter Daley

Journal volume & issue
Vol. 22, no. 3
pp. e21 – e23


Read online

The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised.